Eu­ro­pean reg­u­la­tor says ev­i­dence shows no thy­roid can­cer link to GLP-1s

Cur­rent ev­i­dence doesn’t sup­port a link be­tween GLP-1 re­cep­tor ag­o­nists and thy­roid can­cer, Eu­rope’s drug reg­u­la­tor an­nounced Fri­day fol­low­ing safe­ty con­cerns that have been raised …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER